Clinical Trial Update: Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients With Fasting Dysglycemia [Phase 3]

View source ↗

Summary

Phase 3 trial exploring berberine, curcumin, inositol, banaba, and chromium picolinate for fasting dysglycemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysglycemia

Drugs mentioned

• Banaba (banaba)
• Berberine (berberine)
• Chromium Picolinate (chromium picolinate)
• Curcumin (curcumin)
• Inositol (inositol)

Snippet

Sponsor: University of Pavia | Conditions: Dysglycemia | Phase 3 | Status: COMPLETED